Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. NEO
NEO logo

NEO

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

NEO News

NeoGenomics Launches RaDaR ST for Molecular Residual Disease Detection

Feb 25 2026Newsfilter

NeoGenomics Reports Record Q4 2025 Revenues of $190 Million

Feb 17 2026seekingalpha

NeoGenomics Q4 Earnings Exceed Expectations

Feb 17 2026seekingalpha

NeoGenomics to Announce Q4 Earnings on February 17

Feb 13 2026seekingalpha

NeoGenomics to Report Q4 and Full Year 2025 Results

Jan 27 2026Newsfilter

NeoGenomics (NEO) Projects $727 Million Revenue for 2025 with CFO Transition

Jan 12 2026Newsfilter

NeoGenomics to Present at 44th Annual J.P. Morgan Healthcare Conference

Jan 05 2026Newsfilter

Ryvyl Inc Announces 1-for-35 Reverse Split, Shares Plunge 14.4%

Dec 30 2025Benzinga

NeoGenomics Appoints Jack Kenny to Board of Directors, Enhancing Leadership in Oncology Diagnostics

Dec 30 2025Newsfilter

Neo Performance Materials to Produce 2,000 Tons of Rare Earth Magnets Annually in Estonia

Dec 24 2025CNBC

NeoGenomics Wins Case as Natera Withdraws Appeal

Dec 15 2025Businesswire

NeoGenomics to Fully Launch RaDaR ST Assay in Q1 2026 Following Legal Victory

Dec 15 2025Newsfilter

Netmarble Unveils New Trailer for The Seven Deadly Sins: Origin, Global Pre-Registration Now Open

Dec 12 2025PRnewswire

NeoGenomics to Present RaDaR®1.0 Data at 2025 San Antonio Breast Cancer Symposium

Dec 10 2025Businesswire

NeoGenomics Presents RaDaR Assay Data at 2025 SABCS for Breast Cancer Monitoring

Dec 10 2025Newsfilter

NeoGenomics Presents New Data Enhancing Myeloid Malignancy Diagnosis

Dec 08 2025Newsfilter